These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32641710)

  • 1. Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
    Klöckl MC; Kasparek AK; Riedl JM; Moik F; Mollnar S; Stotz M; Szkandera J; Terbuch A; Gerger A; Niedrist T; Pichler M; Bauernhofer T; Schilcher G; Zitta S; Rosenkranz AR; Friedl C; Stöger H; Posch F
    Sci Rep; 2020 Jul; 10(1):11219. PubMed ID: 32641710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular filtration rate correlation and agreement between common predictive equations and standard 24-hour urinary creatinine clearance in medical critically ill patients.
    Wongpraphairot S; Thongrueang A; Bhurayanontachai R
    PeerJ; 2022; 10():e13556. PubMed ID: 35669965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.
    Funakoshi Y; Fujiwara Y; Kiyota N; Mukohara T; Shimada T; Toyoda M; Imamura Y; Chayahara N; Tomioka H; Umezu M; Otsuki N; Nibu K; Minami H
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):281-8. PubMed ID: 26791871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
    Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
    Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Renal Outcomes after Cisplatin Treatment.
    Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of GFR estimation formula in determination of glomerular filtration rate in kidney donors: Comparison with 24 h urine creatinine clearance.
    Hafeez AR; Idrees MK; Akhtar SF
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):320-5. PubMed ID: 26997385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study to compare the measured glomerular filtration rate compared to estimated glomerular filtration rate in patients undergoing definitive chemoradiation, with platinum agents for various malignancies.
    Rudresh AH; Asati V; Lakshmaiah KC; Lokanatha D; Babu S; Rajeev LK; Lokesh KN; Babu G
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S56-S59. PubMed ID: 30900622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MDRD and the old CKD-EPI equations with the new CKD-EPI equations in kidney transplant patients when glomerular filtration rate is measured with 51Cr-EDTA.
    Borrego Utiel FJ; Ramírez Navarro AM; Esteban de la Rosa R; Bravo Soto JA
    Nefrologia (Engl Ed); 2020; 40(1):53-64. PubMed ID: 31843209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
    Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
    J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of renal function immediately after cessation of continuous renal replacement therapy at the ICU.
    Pieters TT; van Dam MJ; Sikma MA; van Arkel A; Veldhuis WB; Verhaar MC; de Lange DW; Rookmaaker MB
    Sci Rep; 2024 Sep; 14(1):21098. PubMed ID: 39256537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.
    Pedram B; Moghadam AT; Kamyabi-Moghaddam Z; Mavedati O; Beigi BA; Sharabiyani AK; Dezfuli AB; Khalili S; Bahrami AM; Nasoori A
    Tumour Biol; 2015 Jun; 36(6):4495-500. PubMed ID: 25596088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
    McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
    Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics and renal toxicity of cisplatin in cancer patients with renal dysfunction.
    Morita-Ogawa T; Sugita H; Minami H; Yamaguchi T; Hanada K
    Cancer Chemother Pharmacol; 2020 Oct; 86(4):559-566. PubMed ID: 32949266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR.
    Stojkovic V; Delanaye P; Collard G; Ferrante N; Le Goff C; Lutteri L; Cavalier E
    Clin Chim Acta; 2019 Dec; 499():123-127. PubMed ID: 31479650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
    Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
    PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity. A review.
    Daugaard G; Abildgaard U
    Cancer Chemother Pharmacol; 1989; 25(1):1-9. PubMed ID: 2686850
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of renal function in living kidney donors before and after nephrectomy: A Japanese prospective, observational cohort study.
    Kakuta Y; Imamura R; Okumi M; Horio M; Isaka Y; Ichimaru N; Takahara S; Nonomura N; Tanabe K
    Int J Urol; 2019 Apr; 26(4):499-505. PubMed ID: 30818421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Creatinine Clearance and Estimated GFR in Assessing Kidney Function in Living Donor Candidates.
    Garg N; Snyder G; Li J; Mandelbrot D; Poggio ED
    Transplantation; 2020 Mar; 104(3):575-582. PubMed ID: 31205262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
    Elborai Y; Almutereen M; Maher OM; Hafez H; Lee MA; Lehmann L
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):9. PubMed ID: 32372349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.
    Inoue T; Miyazaki J; Ichioka D; Narita S; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Matsui Y; Fujie K; Habuchi T; Nishiyama H
    BMC Cancer; 2018 Mar; 18(1):290. PubMed ID: 29540229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.